DeepMind Health’s Independent Review Panel

Working in healthcare requires regular and independent oversight. We have asked a number of respected public figures to act in the public interest as Independent Reviewers of DeepMind Health.

They meet four times a year to scrutinise our work with the NHS, and will publicly issue an annual statement outlining their findings.

As recommended in their Annual Report 2017, and in recognition of their time commitment and workload, the Independent Reviewers receive an honorarium in line with NHS non-executive appointments. This can either be received as pay directly to the individual, or can be given to a designated charity or other organisation, as chosen by the Reviewer.

The first meeting of the Panel of Independent Reviewers took place on the 14th June 2016. You can read a copy of their 2017 Annual Report here and our response to that here. The Independent Reviewers released their 2018 Annual Report on the 15th June 2018 - you can find a copy of this report here.

The Independent Reviewers are:

  • Professor Donal O'Donoghue – Chair, National Clinical Director Kidney Care, Department of Health 2007-13

  • Elisabeth Buggins, Chair, Eastern Academic Health Sciences Network
  • Eileen Burbidge, Chair, Tech City UK & Partner, Passion Capital

  • Julian Huppert, Former MP, now Director of the Intellectual Forum at Jesus College, Cambridge, and Audit Chair, Cambridgeshire and Peterborough Clinical Commissioning Group (CCG)

  • Matthew Taylor, Chief Executive, Royal Society of Arts (RSA)

  • Professor Sir John Tooke, Professor of Medicine, University College London

  • Maxine Mackintosh, Co-Founder OneHealthTech and Doctoral Student at UCL
  • Jeremy Taylor, Chief Executive at National Voices

Former Reviewers include:

  • Martin Bromiley, Chair, Clinical Human Factors Group & patient safety advocate

  • Mike Bracken, Partner at Public Digital, Board member of Lloyd's of London, Visiting Professor at IIPP at University College London
  • Richard Horton, Editor-in-Chief, The Lancet


In agreeing to become Independent Reviewers of DeepMind Health, each Reviewer has signed a personal pledge that captures both DeepMind Health's commitment to them, and their commitment to DeepMind Health.

In particular, their commitment to ensure public accountability of DeepMind Health and to act with the greater public interest in mind. 

DeepMind Health's response to the Independent Review Panel Annual Report 2018

When DeepMind Health was established in 2016 to address some of the most pressing issues facing global healthcare systems, we wanted to ensure that our pioneering technology was matched with pioneering oversight right from the start. That is why we established the panel of Independent Reviewers, who meet regularly throughout the year with unrestricted access to scrutinise our work. This is an innovative approach within tech companies - one that forces us to question not only what we are doing, but how and why we are doing it. 

We have published our response to this year’s report here, highlighting what we are going to do to build on their recommendations regarding our business model, stakeholder engagement, design, and information governance. As always, we welcome any feedback you have on how we can do things differently.

Discover more from DeepMind Health